So proud of my fellow Uromigo!!

Seriously important and famous Med oncs (so I am told.. what do I know about uro-oncology) visiting my office yesterday!!! Ravindran Kanesvaran Michiel van der Heijden Jayasree Iyer

HERE IN #APCCC24 🇨🇭
IT'S ALL ABOUT THAT PSMA

Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran Simon C
Eleni Efstathiou Dra. María Natalia Gandur Quiroga A/Prof. Shahneen Sandhu
Christopher Sweeney, MBBS Daniel E Spratt Howard Soule
neal shore Robert Reiter Dana Rathkopf
Colin Pritchard…

Asian’s collective effort in reaching the consensus for the Advanced PCa Management ! Thank you Declan Murphy Ian Davis Edmund Chiong for your leadership! Advanced Prostate Cancer Consensus Conference HKSUO

Proud to be named an Advocacy Champion at the #ASCOAdvocacy Summit ! This past year I engaged with my local representatives to improve care for patients w #cancer . #ASCOAdvocacy  

At the 2024 #ASCOAdvocacy Summit , through our great society ASCO, we are urging #Congress to:

👉Help…

Just Out at #AACR24 🇺🇸
Study reveals promising strides in combating clear cell renal cell carcinoma (ccRCC) using cutting-edge CAR T-cell therapy.

✅CTX130, a novel CAR T-cell product targeting CD70, showcased impressive preclinical efficacy, achieving disease control in 81.3%…

A few details IM011 ctDNA presentation (post cystectomy MIBC) #EAU24 - it’s a subset analysis for the ctDNA -ve pts who remained -ve for a year. Analysis started post surgery not at 1 year. Those that became ctDNA +ve were excluded, pts who relapsed on CT were included (1/3)

Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives geriatriconcology.net/article/S1879-… Ravindran Kanesvaran William Dale, MD, PhD, FASCO Supriya Mohile Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Barriers #ProposedActions

Looking forward to the most important meeting in this field Advanced Prostate Cancer Consensus Conference. Honor
to be one of the Asia representatives in this global conference. Both physical and virtual registration are welcome. silke gillessen aurelius omlin Ravindran Kanesvaran Vedang Murthy Hiro SUZUKI

Looking forward to an amazing #APCCC24 in beautiful Lugano next month . Honored to be part of this global multidisciplinary expert panel voting on critical questions related to the management of advance prostate cancer patients. OncoAlert silke gillessen aurelius omlin ESMO - Eur. Oncology

Congratulations Dr. Bernard Escudier Gustave Roussy, recipient of the #IKCSEU24 Nicholas J Vogelzang Humanitarian Award for service to the #kidneycancer community!

Join us for his keynote lecture, when Laurence Albiges will present him with this deserved award. bit.ly/3OjTgfB

WE ARE GETTING READY FOR #APCCC24 🇨🇭

Still Time to Register for this HYBRID meeting
onlineevent.ch/APCCC/2024

#APCCC14 Online is FREE to Certain LMIC's

For those who cant make it
Join OncoAlert & Advanced Prostate Cancer Consensus Conference Ambassadors
Bringing you the TOP conversations in #ProstateCancer …

The OncoAlert 🚨 Newsletter
Covering Oncology March 1-7, 2024
REGISTER AT OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing:
✅🇺🇸 FDA aproval in #NSCLC
✅ NEJM on Enfortumab Vedotin by Tom Powles
✅SBRT☢️ for spinal metastases
✅Dietary interventions in…

EV and pembrolizumab doubling PFS and OS in 1st line UC compared to chemotherapy NEJM

It's #KidneyCancer Awareness Month!
Did you know kidney cancer is the 10th most common cancer in men and 14th in women?
🌐🌍Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.
Let's raise awareness & fight this disease…

👀 Don't miss our discussion with Tom Powles on the latest #OS data readout from the #EV302 study and the potential of #sacituzumab #govitecan .
🎥 Watch Now: buff.ly/49LSX5b

💫🌟Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 #LITESPARK -004 Study🌟💫
aacrjournals.org/clincancerres/…
Eric Jonasch AACR OncoAlert #OncoAlertAF
🎯 84% ORR in pancreatic lesions & 91% in pNETs
🛑 No disease progression in pancreatic lesions;…

Looking forward to this tremendous meeting! Last year was standing room only - please be sure to register early! Neeraj Agarwal, MD, FASCO Giuseppe Banna Ravindran Kanesvaran

JUST IN: New insights from the JAVELIN Renal 101 trial in #RCC in Cancer Discovery. We delve into integrative biomarkers of PDL1 inhibitor avelumab + TKI axitinib (A+Ax) vs. TKI sunitinib (Sun).

A thread 🧵

aacrjournals.org/cancerdiscover…

AACR OncoAlert

👏Great success on VuMedi for #ICUS23 Webcast

In the last 3 months there have been more than 1300 video views from all over the world!

Discover more on VUMEDI Website 👉 ow.ly/tjZu50QuJah

#urology #cancer